Effects of Streak-Based Versus Tally-Based Feedback on Daily Lesson Completion During a 30-Day Digital Health Challenge (Streaks)

February 2, 2026 updated by: University of Pennsylvania
The study will test two interventions for increasing engagement with a target behavior, delivered via a digital web application that participants can access using their phones or computers. For example, in the streak group, users would see how many consecutive days they have completed daily lessons and will be encouraged to extend their streak. In the tally group, participants will see how many cumulative days they have completed daily lessons and will be encouraged to extend their tally.

Study Overview

Detailed Description

The objective of this study is to determine whether tracking people's streak of behavior increases their engagement in that behavior. To test this, the investigators are designing a web application that participants can access daily using their phones or computers. Our previous work suggests that streaks may be useful in motivating people to be more productive. In this study, the investigators change how the investigators operationalize streaks and test streaks in a field context. Because most previous streak research is on how others perceive someone who has a streak, this work is novel because it examines how encouraging someone to achieve and keep a streak affects behavior in a field context. The study will test two interventions for increasing engagement with a target behavior, delivered via a digital web application that participants can access using their phones or computers. For example, in the streak group, users would see how many consecutive days they have completed daily lessons and will be encouraged to extend their streak. In the tally group, participants will see how many cumulative days they have completed daily lessons and will be encouraged to extend their tally. The investigators are interested in whether people complete more daily lessons when a 30-day health challenge app provides daily feedback on their consecutive lessons (each comprising two multiple-choice questions) completed (i.e., "streaks") vs. when it provides feedback on their cumulative lessons completed (i.e., "tallies").

Study Type

Interventional

Enrollment (Actual)

7004

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Our target population is 18 and older adults in the United States who have a valid U.S. phone number and who are willing to make an account on our web application for use during the duration of the study.

Exclusion Criteria:

  • Children under 18 years of age and adults without a valid U.S. phone number

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tally
In the tally group, participants will see how many cumulative days they have completed daily lessons and will be encouraged to extend their tally.
The study will test two interventions for increasing engagement with a target behavior, delivered via a digital web application that participants can access using their phones or computers. For example, in the streak group, participants would see how many consecutive days they have completed daily lessons and will be encouraged to extend their streak. In the tally group, participants will see how many cumulative days they have completed daily lessons and will be encouraged to extend their tally. The investigators are interested in whether people complete more daily lessons when a 30-day health challenge app provides daily feedback on their consecutive lessons (each comprising two multiple-choice questions) completed (i.e., "streaks") vs. when it provides feedback on their cumulative lessons completed (i.e., "tallies").
Experimental: Streaks
In the streak group, participants would see how many consecutive days they have completed daily lessons and will be encouraged to extend their streak
The study will test two interventions for increasing engagement with a target behavior, delivered via a digital web application that participants can access using their phones or computers. For example, in the streak group, participants would see how many consecutive days they have completed daily lessons and will be encouraged to extend their streak. In the tally group, participants will see how many cumulative days they have completed daily lessons and will be encouraged to extend their tally. The investigators are interested in whether people complete more daily lessons when a 30-day health challenge app provides daily feedback on their consecutive lessons (each comprising two multiple-choice questions) completed (i.e., "streaks") vs. when it provides feedback on their cumulative lessons completed (i.e., "tallies").

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total number of lessons completed
Time Frame: 30 days
The key dependent variable is a person's total number of lessons completed during the 30-day Health Daily program. Participants can only complete a given day's lesson on that day; a lesson is only considered complete if both questions that comprise the lesson are answered.
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 23, 2025

Primary Completion (Actual)

January 21, 2026

Study Completion (Actual)

January 21, 2026

Study Registration Dates

First Submitted

October 21, 2025

First Submitted That Met QC Criteria

October 21, 2025

First Posted (Actual)

October 23, 2025

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DBSR-11288
  • P30AG034546-16 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

  • Unique ID
  • Condition assignment
  • Response for the first quiz question for each day
  • Response for the second quiz question for each day
  • Date
  • Female indicator (taken from generize.io)
  • Correct response for the first quiz question
  • Correct response for the second quiz question

IPD Sharing Time Frame

Individual participant data and all supporting materials will become available upon publication of the primary study manuscript and will remain accessible indefinitely thereafter.

IPD Sharing Access Criteria

Individual participant data and all supporting materials will be made openly available through the Open Science Framework (OSF) to any interested party without access restrictions.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preventive Health Care

Clinical Trials on Interventions for increasing engagement with a target behavior

Subscribe